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Background and Objectives
 
Microparticles (MPs) are small phospholipid vesicles of
less than 1 
 
μ
 
m, shed in blood flow by various cell types. These MPs are involved in
several biological processes and diseases. MPs have also been detected in blood
products; however, their role in transfused patients is unknown. The purpose of this
study was to characterize those MPs in blood bank conditions.
 
Materials and Methods
 
Qualitative and quantitative experiments using flow cytometry
or proteomic techniques were performed on MPs derived from erythrocytes con-
centrates. In order to count MPs, they were either isolated by various centrifugation
procedures or counted directly in erythrocyte concentrates.
 
Results
 
A 20-fold increase after 50 days of storage at 4
 
°
 
C was observed (from
3370 
 
±
 
 1180 MPs/
 
μ
 
l at day 5 to 64 850 
 
±
 
 37 800 MPs/
 
μ
 
l at day 50). Proteomic
analysis revealed changes of protein expression comparing MPs to erythrocyte
membranes. Finally, the expression of Rh blood group antigens was shown on MPs
generated during erythrocyte storage.
 
Conclusions
 
Our work provides evidence that storage of red blood cell is associated
with the generation of MPs characterized by particular proteomic profiles. These
results contribute to fundamental knowledge of transfused blood products.
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Introduction
 
Millions of blood products are transfused worldwide every
year; many lives are thus directly concerned by transfusion.
Since the beginning of blood transfusion, numerous efforts
have been made to secure blood products and gain knowledge
about their molecular structures. The progress of proteomics
allows re-examining important issues in blood research [1]
and transfusion science [2] with the tools of large-scale
biology [3].
The three main labile blood products used in transfusion
are erythrocyte concentrates (ECs), platelet concentrates and
fresh-frozen plasma. Each of these products has to be stored
according to its particular components. However, during
storage, modification or degradation of those components
may occur and are known as storage lesions. Among these
lesions, the generation of microparticles (MPs) has been
identified [4–6].
Ageing erythrocytes in blood bank conditions differ from
 
in vivo
 
, therefore, it has been suggested that erythrocyte
physiological ageing process may be accelerated by storage
conditions [7]. Indeed, during storage, several biochemical
and physiological changes occur in ECs, including an
increase in the concentration of free haemoglobin, lipids,
MPs and a pH reduction. Concerning red blood cells (RBCs),
they lose adenosine triphosphate, 2,3-diphosphoglycerate or
potassium and their membrane undergoes various modifica-
tions, such as more rigidity, disruption of phospholipids
asymmetry, protein clustering, lipid raft rearrangement, loss
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of fragments or even release of MPs [8–10]. The exact effects
of storage lesions on transfusion are still unknown.
Microparticles are small phospholipid vesicles of less than
1 
 
μ
 
m in size, also known as microvesicles [11] or ectosomes
[12]. They are released from a variety of cells, such as
platelets, RBCs and white blood cells, or endothelial cells [13].
They contain a subset of proteins derived from their parent
cells. However, MPs are heterogeneous and vary in size,
phospholipid and protein composition. Release of MPs is a
highly controlled process prompted by various stimuli, such
as shear stress, complement attack, proapoptotic stimulation
or damage [14].
Microparticles have long been considered as cell fragments
or ‘debris’ without any biological function. Although their
true biological function is still unknown, there are more and
more indirect evidence that MPs are involved in a broad
spectrum of biological activities, such as haemostasis [15],
thrombosis [13], inflammation [15], transfer of surface
proteins [16] or even angiogenesis [17].
An increase in the number of MPs in plasma has been
demonstrated under various pathological conditions, such as
heparin-induced thrombocytopenia [18], thrombotic throm-
bocytopenic purpura [19], diabetes [20,21], acute coronary
syndromes [22], cardio vascular disease [23] or sepsis [24].
Despite their potential important activities, only few studies
are available on MPs in blood products. It has been demon-
strated that the number of MPs increases with the age of
blood products [25] and that there is a link between the risk
of transfusion complication and the age of the transfused
blood products [26,27]. Thus, an appealing hypothesis is that
a high number of MPs in ECs is linked to adverse transfusion
reactions. In addition, Koch 
 
et
 
 
 
al
 
. recently demonstrated a
link between the age of transfused RBCs and post-transfusion
complications [28], indicating that progress in the knowledge
of stored RBCs biology is urgently needed.
In order to have a better understanding of MPs in stored
ECs, qualitative and quantitative experiments using flow
cytometry or proteomic techniques were developed and
performed. The goals of this study were: (i) to test centrifugation
methods for the isolation of MPs from ECs; (ii) to count MPs
directly in ECs and in their supernatant fraction; and (iii) to
gain insight into the protein content of MPs as compared to
RBC membranes, and (iv) to evaluate if erythrocyte-derived
MPs also express Rhesus antigens on their surface.
 
Materials and methods
 
Erythrocyte concentrates
 
Whole blood was collected and prepared at the Lausanne or
Bern blood banks, according to standardized procedures.
Only ECs that did not satisfy quality criteria for transfusion
were used for this study, notably those collected from donors
presenting with elevated levels of alanine transaminases
(ALAT). Briefly, 450 
 
±
 
 50 ml of whole blood was drawn by
venipuncture and collected in blood bags (Fenwal, Lake
Zurich, IL, USA) containing the anticoagulant solution
(citrate–phosphate–dextrose). Leucocytes and platelets were
then removed by filtration. After separation of plasma from
erythrocytes by centrifugation, RBCs were finally suspended
in 100 ml of preservative solution sodium–adenine–glucose–
mannitol. For the experimental purpose of this study, ECs
were stored up to 50 days at 4
 
°
 
C instead of 42 days, the usual
expiration date for concentrates in sodium–adenine–
glucose–mannitol solution.
 
Flow cytometry analysis and microparticles counts 
in erythrocyte concentrates
 
Samples were analysed on a FACScalibur flow cytometer
with CellQuest pro software (BD Biosciences, Franklin Lakes,
NJ, USA). Flow cytometer was daily calibrated with CaliBRIT™
3 kit (BD Biosciences) containing different fluorescent beads.
Size events were defined using flow cytometry size beads of
1–1·4 
 
μ
 
m (Spherotech, Lake Forest, IL, USA). For the different
windows used, the flow cytometer was set on a logarithmic
scale.
Fluorescein isothiocyanate (FITC) anti-human CD47 (BD
Pharmingen, San Diego, CA, USA) and phycoerythrin (PE)
anti-human CD235a (or glycophorin A) (BD Pharmingen)
were the two antibodies used to tag erythrocyte MPs.
Moreover, experiments have been done with FITC human
annexin V (BD Pharmingen) that tags negative phospholipids
present on MPs surface.
Microparticles counts were determined in the supernatant
of a stored EC at 4
 
°
 
C for 38 days, after various centrifugation
conditions (870 
 
g
 
, 1850 
 
g
 
, 2550 
 
g
 
 and 3250 
 
g
 
). Four samples
of 50 ml from the EC were spun down twice for 20 min, and
100 
 
μ
 
l of supernatant was then mixed with 3 
 
μ
 
l of FITC
anti-human CD47 or 3 
 
μ
 
l PE anti-human CD235a or both for
double staining. After 20 min of incubation on an orbital
shaker in the dark at 4
 
°
 
C, 400 
 
μ
 
l of phosphate-buffered saline
(PBS) was added and flow cytometry analysis was carried out
within 1 h in a Trucount™ tube (BD Biosciences). Isotypic
controls were performed with PE immunoglobulin G2b
(IgG2b) or FITC IgG1 (both from Diaclone, Besançon, France).
MPs were also determined in the supernatant of 13 different
ECs stored from 2 to 50 days at 4
 
°
 
C after two centrifugations
at 1850 
 
g
 
 for 20 min. Measurements were done in triplicates.
The flow cytometer settings for counting MPs in supernatants
were as follows (detector: voltage): FSC: E00, SSC: 360, FL1:
500–600, FL2: 500–600 and FL3: 570.
Finally, to avoid pre-analytical variability due to centrifu-
gation conditions, MPs counts were determined in ECs from
seven different blood donors (without centrifugation). For
each EC, six measurements were performed from day 2 to day
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50 of storage at 4
 
°
 
C. Red blood cells were carefully mixed
with the storage solution, and 5 
 
μ
 
l of the RBC suspension was
mixed with 4 
 
μ
 
l of FITC anti-human CD47 for 5 seconds. The
mixture was then incubated for 20 min on orbital shaker in
the dark. Lastly, 4 
 
μ
 
l of the solution was diluted to 1 ml with
0·9% NaCl in a Trucount™ tube, and was directly analysed by
flow cytometry. Isotypic controls were performed with FITC
IgG1 (Diaclone). The flow cytometer settings for counting
MPs in concentrates were as follows (detector: voltage): FSC:
E00, SSC: 300, FL1: 650, FL2: 520 and FL3: 600.
 
Proteomics
 
Proteomic analysis was done on MPs and erythrocyte
membranes of the same 42-day stored ECs. MPs were
obtained after three centrifugations (1850 
 
g
 
 twice and 3200 
 
g
 
once, 20 min at 4
 
°
 
C) and the supernatant containing MPs
was collected. Then, three ultracentrifugations at 120 000 
 
g
 
for 90 min at 4
 
°
 
C were done, each time pellets were suspended
in PBS. To obtain erythrocyte membranes, RBCs were washed
in PBS 10
 
×
 
 and spun at 1850 
 
g
 
 for 20 min at 4
 
°
 
C three times.
Collected pellets were then washed in deionized water and
after another centrifugation at 1850 
 
g
 
 for 20 min at 4
 
°
 
C,
pellets were collected and prepared for future analysis.
To determine the quantity of sample to load, protein
concentration of each sample was measured according to the
Bradford’s method [29]. For sodium dodecyl sulphate–
polyacrylamide gel electrophoresis (SDS-PAGE), 30 
 
μ
 
g of
proteins was loaded onto a 4–12% NuPAGE Novex Bis-Tris
polyacrylamide gel (Invitrogen, Carlsbad, CA, USA). The
migration was carried out at constant voltage (200 V).
For mass spectrometry (MS) analysis, SDS-PAGE was run
as previously described, but 300 
 
μ
 
g of proteins was loaded.
Upon electrophoresis completion, the gels were rinsed twice
with deionized water and stained with colloidal Coomassie
blue (National Diagnostics, Atlanta, GA, USA) overnight. The
gels were destained with deionized water. Bands of interest
were excised from the gels and transferred into an Eppendorf.
In-gel proteolytic cleavage with sequencing-grade trypsin
(Promega) was automatically performed in the robotic
workstation Investigator ProGest (Perkin Elmer Life Sciences)
according to the protocol of Shevchenko 
 
et
 
 
 
al
 
. [30]. Digests
were evaporated to dryness and resuspended in 3 
 
μ
 
l of 
 
α
 
-
cyano-hydroxycinnamic acid matrix [5 mg/ml in 60% (v/v)
acetonitrile : water), of which 0·7 
 
μ
 
l was deposited in duplicate
on a target plate. Matrix-assisted laser desorption/ionization
MS (MALDI-MS)/MS analysis was performed on a 4700
Proteomics Analyser (Applied Biosystems, Framingham,
MA, USA). After MALDI – Time of Flight (TOF)/MS
analysis, internal calibration on trypsin autolysis peaks
and subtraction of matrix peaks, the 10 most intense ion
signals were selected for MS/MS analysis. Non-interpreted
peptide tandem mass spectra were used for direct interrogation
of the Uniprot (Swissprot + TrEMBL) database using Mascot
2·0 (http://www.matrixscience.com). The mass tolerance for
database searches was 50 p.p.m. MASCOT was set up to only
report peptide matches with a score above 14. With the
parameters used, the threshold for statistical significance
(
 
P 
 
< 0·05) corresponded to a total (protein) MASCOT score of
33. Proteins scores above 80 were automatically considered
valid, while all protein identifications with a total MASCOT
score between 33 and 80 were manually validated. Validation
included examination of the peptide root mean square mass
error and of individual peptide matches. Peptide matches
were validated only if at least an ion series of four consecu-
tive y ions were matched, in addition to ions belonging to
other series. Generally, only proteins matched by at least two
peptides were accepted.
 
Western blotting
 
From 20 to 50 
 
μ
 
g of proteins from the samples described
before (MPs and erythrocyte membranes) were loaded onto a
4–12% NuPAGE Novex Bis-Tris polyacrylamide gel (Invitrogen).
After migration, carried out at constant voltage (200 V), pro-
teins were transferred to polyvinylidene fluoride membranes
using a Novex blot module (Invitrogen) for 1 h 45 min at
fixed voltage (30 V), according to the manufacturer’s
instruction. After transfer, blotted membranes were soaked
overnight in blocking solution with PBS, 0·1% Tween-20 (v/
v), 5% milk and 1% BSA (w/v). Four Western blots were done,
each one with a different antibody, namely, anti-human
CD235a (Santa Cruz Biotechnology, Santa Cruz, CA, USA),
anti-human actin (Sigma, Saint Louis, MO, USA), anti-human
stomatin (Proteintech Group, Chicago, IL, IL) and anti-human
CD47 (from Santa Cruz or from AbCam, Cambridge, UK). All
antibodies were used at a dilution of 1 : 500. The goat
anti-rabbit and goat anti-mouse horseradish peroxidase-
conjugated secondary antibodies (Dako, Baar, Switzerland)
were both used at a dilution of 1 : 10 000. Subsequent
visualization was performed using enhanced chemilumines-
cence (GE Healthcare, Uppsala, Sweden). The signal was
finally captured using X-ray film.
 
Expression of Rhesus antigens
 
Flow cytometry was used to determine the presence of Rh
antigens on MPs generated during storage. MPs were first
isolated from the supernatant of an EC after two centrifugations
at 1850 
 
g
 
 at 4
 
°
 
C for 20 min. The supernatant was then spun
down at 18 000 
 
g
 
 for 5 min to pellet MPs. Pellet was dissolved
in 100 
 
μ
 
l of PBS. One 
 
μ
 
l of the primary antibody (anti-D,
anti-C, anti-c, anti-E and anti-e, respectively) was later
added and mixed on orbital shaker for 90 min. IgM anti-D
were obtained from Orthobiotech (Bridgewater, NJ, USA),
whereas IgM anti-C, IgM anti-c, IgM anti-E and IgM anti-e
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were obtained from Biotest (Dreichen, Germany). One 
 
μ
 
l of
the secondary antibody was then added, and after 1 h on
orbital shaker in the dark, 400 
 
μ
 
l of PBS was added, and
samples were analysed by flow cytometry within an hour.
Secondary antibody directed against primary IgM was FITC
anti-human IgF(ab) from Chemicon (Melbourn, Australia). To
demonstrate the presence of various Rh antigens on MPs,
blood samples expressing different Rh phenotypes, such as
DCCee, DccEE or dccee, were selected. The antithetical
phenotype was used with each antibody as a negative control.
 
Results
 
Microparticle counts
 
Using flow cytometry, MPs clearly were distinguished from
RBCs by their size as well as by the negatively charged
phospholipids on their outer membrane detected by annexin
V. Indeed, the great majority of MPs were annexin V-positive,
while merely a few percentage of erythrocytes were positive.
MPs were also identified using either anti-CD47, anti-CD235a
or both antibodies, without any differences in their numbers
according to the choice of the antibody (Figs 1 and 2).
In both methods used, an increase in the number of MPs
during storage of ECs was observed (Figs 2 and 3). The
number of MPs was clearly related to centrifugation conditions
(Fig. 2). In the measurements performed directly in the
concentrate, the number of MPs increases about 20-fold after
50 days of storage at 4
 
°
 
C and considerably varies among
different samples; it starts from 3370 + 1180/
 
μ
 
l after 6 days,
up to 64 850 + 37 800/
 
μ
 
l after 50 days of storage (Fig. 3).
The intra-assay coefficient of variation was evaluated. With
both methods, the coefficient was less than 15%, even after
50 days of storage (data not shown). Nonetheless, and
without evident explanation, we observed a huge individual
variation of the MPs counted among different donors.
Fig. 1 Flow cytometry analysis of microparticles 
from a supernatant after centrifugation of 
erythrocyte concentrate. (a) Events that were 
sorted according to their size and shape. Two 
different regions were determined; microparticles 
and beads. A precise number of beads were used 
to determine the number of microparticles in 
each sample. Histograms represent events from 
the microparticle region (b–e) of (a) according to 
their fluorescence (due to an FITC- or PE-labelled 
antibody). M1 represents non-stained events 
whereas M2 shows stained event. (b) 
Microparticles stained with annexin V; (c) 
microparticles stained with anti-CD47 FITC; and 
(d) microparticles stained with anti-CD235a. FITC, 
fluorescein isothiocyanate; PE, phycoerythrin. In 
(e) and (f), microparticles were derived from an 
erythrocyte concentrate from a donor typing 
dccee. In this example, microparticles were 
negative for anti-C antibody (e), while they were 
positive for anti-c antibody (f).
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Proteomics
 
Sodium dodecyl sulphate–polyacrylamide gel electrophoresis
showed a number of large as well as discrete bands obtained
after electrophoresis of RBC membranes (Fig. 4, lane A) and
MPs (Fig. 4, lane B). A major difference was observed in the
25–35 kDa region; thus, in order to perform protein identifi-
cation, bands of interest stained with Coomassie blue were
excised and proteins were identified by MS. Table 1 lists the
proteins identified in the three excised bands of lane A
(erythrocyte membranes) and lane B (MPs). Not surprisingly,
abundant proteins such as carbonic anhydrases or peroxire-
doxins were identified both in RBC membranes and MPs
with good sequence coverage. A set of 14-3-3 proteins was
also identified in both samples: 14-3-3 proteins are abundant
and ubiquitous proteins [31] that act as regulators of a number
of processes, such as modulation of protein kinase activities,
signal transduction [32]. Remarkably, 14-3-3
 
ζ
 
 has been
shown to be implicated in GPIb-IX-V translocation to the
cytoskeleton during platelet activation [33]. It was thus not
surprising to find 14-3-3 proteins in RBC ghosts. The gel
band that appeared to be quantitatively the most different
between lanes A and B was identified as stomatin, identified
in MPs with a score of 1131, a sequence coverage of 76·4%
from 46 peptides, whereas it was identified in RBC membranes
with a score of 156, a sequence coverage of 14·9% from four
peptides, indicating that stomatin was largely enriched in MPs
compared to erythrocyte membranes.
Interestingly, some of the identified proteins did not have
molecular weights that corresponded to their respective
position on the gel. For example, haemoglobin subunits 
 
α
 
and 
 
β
 
, which have a molecular weight of about 15–16 kDa,
were observed in the region corresponding to 25–35 kDa on
the gel. However, it has been documented that denatured and
cross-linked haemoglobin strongly binds to the cytoskeleton
during RBC storage in blood banking conditions [34]. It is
thus highly probable that the haemoglobin subunits identified
were present as homogeneous or heterogeneous dimers.
Additionally, Band 3 (a major membrane protein) as well as
Rhesus protein were identified in MPs only, from three and
two sequenced peptides, respectively. For Band 3, the identified
peptides correspond to the cytoplamic domain of the protein
(spanning the region 117–180), which means that the Band 3
Fig. 2 Count of microparticles in supernatant of 
erythrocyte concentrates (ECs). The number of 
microparticles measured decreased with 
increasing centrifugation speed (test on one EC 
stored for 38 days). Note that the numbers 
measured were identical with the two antibodies 
used in this study (anti-human CD235a or CD47). 
The inset shows an increase in the number of 
microparticles in supernatant of ECs during 
storage (after centrifugation at 1850 g, here 
anti-human CD235a was used).
Fig. 3 Count of microparticles directly in erythrocyte concentrates during 
storage (without centrifugation). Data are expressed as the mean ± SD 
experiment (n = 7). At day 5, 3371 ± 1188 microparticles/μl were counted, 
whereas at day 50, their numbers were 64 858 ± 37 846 microparticles/μl. 
Anti-human CD47 was used to stain microparticles.
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Journal compilation © 2008 Blackwell Publishing Ltd., Vox Sanguinis (2008) 95, 288–297
Microparticles in stored red blood cells 293
fragment that appears on the gel in the 25–35 kDa region
belongs to the cytoplasmic domain of the protein. The Rhesus
protein was identified from two peptides covering the 17 last
amino acids on the C terminus of the protein sequence. Of
interest, Mascott allowed the identification of Rh peptides
(Table 1; lane B of Fig. 4). However, it was not possible to
discriminate between RhD and Rh(CE) proteins, a well-known
problem in proteomics [35]. Nevertheless, the presence of
various Rh antigens at the surface of MPs was confirmed by
flow cytometry (see below).
Western blots
Western blotting confirmed the presence of CD235a, actin
and stomatin on RBC membranes as well as on MPs, with a
clear reduction of actin and an accumulation of stomatin on
MPs (Fig. 4). However, using this technique and the antibodies
available, neither CD47 nor Rh-proteins could be detected
after SDP-PAGE. With blot techniques, no quantitative
difference was observed between MPs samples from ECs
stored for 5 or 42 days.
Rhesus systems
The presence of blood group antigens of Rhesus system on
MPs surface was investigated by flow cytometry using
specific antibodies. In each assay, positive and negative
samples were selected for the corresponding antigen (Fig. 1e,f ).
By this approach, the presence of C, c, D, E or e antigens was
observed on MPs when they were present on the RBCs from
which they derived. However, it was not possible to exclude
that a population of MPs was Rh negative.
Discussion
There is no standardized method to count MPs. Several
approaches have been proposed in the literature, the majority
dealing with platelet MPs from whole blood or platelet
concentrates. Centrifugation speeds, for MPs characterization,
varied from 200 g to 13 000 g [36]. In our hands, complete
elimination of RBCs from supernatant at low centrifugation
was obtained after two centrifugation at 1850 g for 20 min.
Annexin V is frequently used to detect phosphatidylserine, a
negatively charged phospholipid known to be present on the
outer leaflet of apoptotic cells as well as on MPs of various
origins [18]. In this study, MPs were counted using flow
cytometry with different antibodies, notably anti-CD235a
and anti-CD47. These antibodies were chosen because both
are reactive towards RBC membrane molecules known to be
present on MPs [14,29].
Counting MPs directly within the homogenized ECs
appeared as the simplest approach, avoiding handling,
centrifugation and washing. The drawbacks were due to the
presence of a great number of RBCs, the need of quite large
Fig. 4 Sodium dodecyl sulphate–polyacrylamide 
gel electrophoresis (SDS-PAGE) of erythrocyte 
membranes and microparticles, both were from a 
42-day stored erythrocyte concentrate. The gel 
was stained with Coomassie blue (for better 
compatibility with mass spectrometry). Inset 
shows enlargement of Coomassie blue-stained 
gel used for the preparation of the bands 
submitted to mass spectrometry analysis. Western 
blot analysis points out the variation of protein 
expression. Thus, by comparing erythrocyte 
membranes and microparticles, a clear reduction 
of actin and an accumulation of stomatin were 
observed on microparticles. The staining of 
CD235a (glycophorin A) was similar in both gels.
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amount of antibodies and an intra-sample variability in the
number of MPs counted. In addition, samples cannot be
stored, contrasting with supernatants containing MPs, which
can be kept at 4°C or even be frozen before being evaluated
by flow cytometry. Disadvantages of working with supernatants
were related to the handling procedures and, more importantly,
to the influence of centrifugation conditions. After centrifu-
gation, residual RBCs were eliminated. However, a number of
MPs appeared to be pelleted together with RBCs (Fig. 2). In
any case, an increase in the number of MPs in ECs during
storage was observed, even if the number of MPs counted
differs according to the method. From our results, it is really
clear that the number of MPs counted in EC was dependent
on the centrifugation protocols.
Whereas it cannot be excluded that MPs from platelets,
white blood cells or endothelial cells be present in the starting
EC, this increase in total of MPs count can be attributed only
to the shedding of MPs from RBCs present in the concentrate.
Noteworthy, the increase varied quite importantly from
donor to donor. The reason of such a variation is unknown,
but factors like ABO blood group, age, fasting or sex of blood
donor may have a role and should be investigated. Finally,
the most important parameter associated with the number of
MPs in ECs was the duration of storage at 4°C.
A set of experiment with three ECs satisfying quality criteria
for transfusion (normal ALAT level) was done and gave very
similar, if not identical MPs count when compared to ECs
with elevated ALAT level (data not shown).
Microparticle tend to aggregate at high concentration,
either related to the methods used for their isolation or to
their ‘intrinsic’ adhesion properties, which have been already
evidenced with platelet-derived MPs [16]. We observed heaps
of erythrocyte MPs by electron microscopy (data not shown),
thus erythrocyte MPs may also have adhesion properties.
This observation is important for the quantitative results,
because MPs counts are evaluated according to their sizes
Table 1 Proteins identified in the region 25–35 kDa of RBC membranes (lane A of Fig. 4) and microparticles (lane B of Fig. 4). Reported are the sequence 
coverage (%) and the number of sequenced peptides
AC Entry name Protein name
MW 
(Da)
RBC 
(sequence 
coverage %)
RBC 
(identified 
peptide)
MPs 
(sequence 
coverage %)
MPs 
(identified
peptide)
P31946 1433B_HUMAN 14-3-3 protein β/α 28 082 25·2 7 16·7 4
P62258 1433E_HUMAN 14-3-3 protein epsilon 29 174 34·9 11 NO NO
P61981 1433G_HUMAN 14-3-3 protein γ 28 303 NO NO 13·4 4
P27348 1433T_HUMAN 14-3-3 protein θ 27 764 14·3 5 NO NO
P63104 1433Z_HUMAN 14-3-3 protein ζ/δ 27 745 44·5 11 8·2 2
P02730 B3AT_HUMAN Band 3 anion transport protein 101 792 NO NO 6·8 3
Q4TWB7 Q4TWB7_HUMAN β-Globin chain (Fragment) 11 487 93·3 15 NO NO
P07738 PMGE_HUMAN Bisphosphoglycerate mutase 30 005 45·9 13 37·8 10
P00915 CAH1_HUMAN Carbonic anhydrase 1 28 870 72·8 27 65·5 20
P00918 CAH2_HUMAN Carbonic anhydrase 2 29 246 72·7 25 71·9 15
P07451 CAH3_HUMAN Carbonic anhydrase 3 29 557 36·2 8 17·7 4
A0N071 A0N071_HUMAN δ-Globin chain (haemoglobin δ) 16 055 55·1 10 55·1 9
P27105 STOM_HUMAN Erythrocyte band 7 integral membrane protein 31 731 14·9 4 76·4 43
P17931 LEG3_HUMAN Galectin-3 26 188 11·6 3 NO NO
P78417 GSTO1_HUMAN Glutathione transferase ω-1 27 566 33·2 10 7·9 2
P69905 HBA_HUMAN Haemoglobin subunit α 15 258 71·1 9 71·1 9
P68871 HBB_HUMAN Haemoglobin subunit β 15 998 83·0 16 93·9 15
Q16775 GLO2_HUMAN Hydroxyacylglutathione hydrolase 28 860 8·8 2 NO NO
P30041 PRDX6_HUMAN Peroxiredoxin-6 25 035 25·9 6 16·1 4
P18669 PGAM1_HUMAN Phosphoglycerate mutase 1 28 804 8·3 2 NO NO
Q06323 PSME1_HUMAN Proteasome activator complex subunit 1 28 723 16·5 4 NO NO
P25788 PSA3_HUMAN Proteasome subunit α type 3 28 433 6·7 2 NO NO
P25789 PSA4_HUMAN Proteasome subunit α type 4 29 484 12·3 4 NO NO
P60900 PSA6_HUMAN Proteasome subunit α type 6 27 399 9·3 2 NO NO
O14818 PSA7_HUMAN Proteasome subunit α type 7 27 887 21·4 4 NO NO
P00491 PNPH_HUMAN Purine nucleoside phosphorylase 32 118 59·5 16 17·6 4
Q0KG01 Q0KG01_HUMAN RhD protein 45 052 NO NO 4·1 2
AC, accession number; MW, molecular weight in Da; NO, not observed.
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using flow cytometry. Thus, in samples with high concentrations
of MPs, their number are probably underestimated due to the
fact that MPs tend to form more heaps and flow cytometry
does not distinguish between big MPs or aggregated MPs,
even if the technique is the method of choice to study MPs
[36]. So, the counting approach of MPs presented in this
study (as well as in other published studies) should be
considered as semiquantitative.
According to our proteomic and Western blot studies, MPs
from stored RBCs appeared to be enriched with stomatin.
Remarkably, the enrichment in stomatin, depletion in actin
and stability of glycophorin A (as compared to erythrocyte
membranes) were the same at day 7 and day 40. In this
respect, MPs generated after a few days of storage or at the
end of storage appear equivalent. Those results are well in
line with previous reports [37,38]. Stomatin is a membrane
protein involved in regulation of monovalent cation transport
through lipid membranes [39]. Interestingly, stomatin (which
has a structure similar to caveolin) is a major lipid-raft
component of erythrocytes [40]. Precise reasons of stomatin
enrichment in MPs are not well known and are still subject
of investigation, but may have a role in membrane microdo-
mains modulation leading to membrane budding and MPs
release [38]. The cell membrane plays a key role in the
formation of MPs. Indeed, following a stimulus, increase in
intracellular Ca++ occurs and activates proteases that cleave
cytoskeleton proteins (actin and spectrin). Membrane is thus
less rigid and can bud until formation of MPs. Furthermore,
the asymmetry between the neutral phospholipids on the
outer membrane and the negatively charged phospholipids
on the inner membrane held by translocases is broken [37].
Consequently, phosphatidylserine, a negatively charged
phospholipid, is also located on the outer side of MP
membrane. Using annexin V, flow cytometry confirmed that
phosphatidylserine was present on MPs derived from
erythrocytes but essentially lacked from fresh RBCs and was
externalized in only a small fraction of old RBCs. Finally, as
shown by Western blots, actin was not a dominant protein of
MPs when compared to RBC membranes.
The precise reasons for the huge increase in MP counts
during storage of EC observed in this study are unknown.
Although controversial, it has been speculated that MPs
could be a means for erythrocytes to prevent a premature
removal from circulation when they are still functional or
when lesions are reversible [41]. According to this hypothesis,
MPs would allow erythrocytes to clear away non-functional
molecules that would trigger an apoptosis-like pathway, or
to get rid of autologous IgG binding senescent erythrocytes
for removal by spleen macrophages [8,10,42]. Indeed, Willekens
et al. have recently shown that MPs contain erythrocyte
removal proteins such as bound IgG and altered Band 3, and
thus concluded that microvesiculation serves as a removal
pathway for damaged proteins [42]. Complementarily, a
detailed proteomic investigation of RBCs and MPs generated
during storage led Bosman et al. to hypothesize that there are
two possible mechanisms at work in MPs generation: first,
immunoglobulins could bind to senescent surface proteins,
thereby triggering microvesiculation. Alternatively, oxidatively
damaged proteins could bind to or disrupt normal inter-
actions within the cytoskeleton, thereby altering the tight
balance between the cytoskeleton pressure and the membrane
bending stress [10]. These two passive mechanisms could well
be only one part of the picture, because activation of protein
kinases has been demonstrated to trigger phosphatidylserine
exposure in erythrocytes [43], as well as tight concomitant
regulation of microvesiculation and Band 3 phosphorylation/
dephosphorylation [44]. Lastly, lysophosphatidic acid, an
important lipid mediator, has been shown to be able to trigger
phosphatidylserine exposure and microvesiculation in
erythrocytes [45]. These studies show that MP generation can
be triggered by various processes, including senescence or
protein alteration, external or internal exposure to lipid
mediators, and that phosphorylation plays a role in microve-
siculation control.
In this study, we also showed evidence that Rhesus blood
group antigens are located on erythrocyte MPs. The presence
of theses proteins was evidenced by determination of Rh
peptides by MS and by flow cytometry, indicating that the
antigenic parts of the Rh proteins are located outside MPs
membranes. The presence of the Rh complex is also reinforced
by the expression of CD47 (shown by flow cytometry), which
is a member of the complex within the RBC membrane. Those
blood group antigens present on MPs are likely immunogenic,
and thus may play a potential role in RBC alloimmunization
after transfusion.
As recently shown by Koch et al., there is a link between
duration of RBC storage and complications after cardiac
surgery [28]. According to the result of this research, trans-
fusion of erythrocytes that have been stored for more than
14 days in patients undergoing cardiac surgery significantly
increases the risk of postoperative complications and reduces
survival time. Reasons for such complications remain unclear;
however, storage lesions may be a possible mechanism.
Physicochemical changes occurring during storage of ECs are
indeed known to affect RBCs function and viability. Our
results confirm that important changes occur during storage
of RBCs and that storage techniques allowing a better con-
servation of the integrity of the membrane should be thus
developed in the future.
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